Purchase Order 75N93022P00218
- Not listed
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The $6,235.00 purchase order is for the delivery of 82 units of a radiopharmaceutical product at a unit price of $75.00. The contract has no set-aside designation and is part of Cardinal Health 414's ongoing work supporting federal nuclear...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract, valued at $3,835.00, is a firm fixed-price purchase order for various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67. The products will be used to support nuclear...
- This federal contract award is for the procurement of F-18 FDG (fluorine-18 fluorodeoxyglucose), a radioactive chemical used for imaging and scans, by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), a civilian federal agency. The contract was awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., a global healthcare services company. The contract is a firm fixed-price purchase order with a ceiling value of...
- This federal contract award, valued at $64,310.00, was issued by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of the parent company Cardinal Health, Inc. The contract is for the delivery and administration of the radiopharmaceutical fluorine-18 FDG in a shielded system. Cardinal Health 414 is a major supplier of radiopharmaceuticals and specialty pharmaceuticals to federal healthcare agencies, including the Department of Veterans Affairs...
- This federal contract award, with ID 75N90018P00478, was issued by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The $24,587.55 firm-fixed-price purchase order is for the delivery of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, to support nuclear medicine, oncology, and diagnostic...
- This is a delivery order contract awarded by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $65,053.00 firm fixed-price contract is for the supply of an F-18 FDG in shielded delivery and administration system, which is a radiopharmaceutical product used in nuclear medicine imaging procedures. Cardinal Health 414 is a major provider of radiopharmaceuticals and other specialty medical products to various federal...
- This federal contract award is to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The contract, valued at $21,664.10, is a firm fixed-price purchase order issued by the National Institutes of Health (NIH) Clinical Center. It is not set aside for any specific business designation. The contract is for the delivery of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and...
- This federal contract award, with an ID of 75N90019P00314, is a purchase order for $20,437.06 awarded to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The contract is for the supply of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride), to the National Institutes of Health...
- This $22,829.59 firm fixed-price federal contract was awarded by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of a variety of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies such as Xofigo (radium-223 dichloride) for prostate cancer treatment. These products...
- This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., a global healthcare services company. The contract, valued at $4,251.00, is a Firm Fixed Price Delivery Order awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency. The contract provides radiopharmaceuticals, radioactive isotopes, diagnostic imaging agents, and specialty pharmaceuticals to support nuclear medicine, oncology, and other diagnostic imaging services at...
This federal contract award, with ID 75N93022P00218, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $11,355.75 firm fixed-price purchase order is for the delivery of 100 doses of F-18 FDG UD, up to 15 mCi, with a completion date of October 20, 2022. Cardinal Health 414 is a major provider of radiopharmaceuticals, radioactive isotopes, and specialty pharmaceuticals to federal healthcare agencies, including the Department of Veterans Affairs, Department of Defense, and National Institutes of Health. This contract award is likely part of the company's broader Indefinite Delivery Vehicle (IDV) contracts with these agencies, which can range from $1 million to $39.8 million in value and cover ongoing deliveries of a variety of nuclear medicine products to support patient care and research programs. The contract does not utilize any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($7k) | 8/10/23 | |
| P00001 | Other Administrative Action | $0 | 10/20/22 | |
| Not listed | Not listed | $18.0k | 12/28/21 |